High TGFβ-Smad Activity Confers Poor Prognosis in Glioma Patients and Promotes Cell Proliferation Depending on the Methylation of the PDGF-B Gene

Cancer Cell

Volumn 11, Issue 2, 2007, Pages 147-160

  Bruna, Alejandra ^a   Darken, Rachel S ^a   Rojo, Federico ^a   Ocaña, Alberto ^a   Peñuelas, Silvia ^a   Arias, Alexandra ^a   Paris, Raquel ^c   Tortosa, Avelina ^d   Mora, Jaume ^c   Baselga, Jose ^a   Seoane, Joan ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^c HOSPITAL SANT JOAN DE DÉU   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

SIGNALING

Indexed keywords

PLATELET DERIVED GROWTH FACTOR B; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; SMAD2 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; CULTURE MEDIUM; EPITHELIUM CELL; GENE; GLIOMA; HUMAN; HUMAN CELL; METHYLATION; PDGF B GENE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; ASTROCYTOMA; BRAIN TUMOR; DNA METHYLATION; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GLIOBLASTOMA; INFANT; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; PRESCHOOL CHILD; SIGNAL TRANSDUCTION; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; DNA METHYLATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; GLIOMA; HUMANS; INFANT; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-SIS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD7 PROTEIN; SURVIVAL RATE; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 33846821916     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2006.11.023     Document Type: Article

References (35)

1. Arteaga C.L. Inhibition of TGFβ signaling in cancer therapy. Curr. Opin. Genet. Dev. 16 (2006) 30-37
2. Chow E.K., O'Connell R.M., Schilling S., Wang X.F., Fu X.Y., and Cheng G. TLR agonists regulate PDGF-B production and cell proliferation through TGF-β/type I IFN crosstalk. EMBO J. 24 (2005) 4071-4081
3. Dai C., Celestino J.C., Okada Y., Louis D.N., Fuller G.N., and Holland E.C. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev. 15 (2001) 1913-1925
4. Derynck R., and Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425 (2003) 577-584
5. Derynck R., Akhurst R.J., and Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat. Genet. 29 (2001) 117-129
6. Druker B.J. Imatinib as a paradigm of targeted therapies. Adv. Cancer Res. 91 (2004) 1-30
7. Dumont N., and Arteaga C.L. Targeting the TGFβ signaling network in human neoplasia. Cancer Cell 3 (2003) 531-536
8. Fredriksson L., Li H., and Eriksson U. The PDGF family: Four gene products form five dimeric isoforms. Cytokine Growth Factor Rev. 15 (2004) 197-204
9. Guo P., Hu B., Gu W., Xu L., Wang D., Huang H.J., Cavenee W.K., and Cheng S.Y. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am. J. Pathol. 162 (2003) 1083-1093
10. Holland E.C. Gliomagenesis: Genetic alterations and mouse models. Nat. Rev. Genet. 2 (2001) 120-129
11. Jennings M.T., Hart C.E., Commers P.A., Whitlock J.A., Martincic D., Maciunas R.J., Moots P.L., and Shehab T.M. Transforming growth factor beta as a potential tumor progression factor among hyperdiploid glioblastoma cultures: Evidence for the role of platelet-derived growth factor. J. Neurooncol. 31 (1997) 233-254
12. Jin H.M., Brady M.L., and Fahl W.E. Identification and characterization of an essential, activating regulatory element of the human SIS/PDGFB promoter in human megakaryocytes. Proc. Natl. Acad. Sci. USA 90 (1993) 7563-7567
13. Joshi B.H., Plautz G.E., and Puri R.K. Interleukin-13 receptor alpha chain: A novel tumor-associated transmembrane protein in primary explants of human malignant gliomas. Cancer Res. 60 (2000) 1168-1172
14. Kang Y., Chen C.R., and Massague J. A self-enabling TGFβ response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol. Cell 11 (2003) 915-926
15. Kang Y., He W., Tulley S., Gupta G.P., Serganova I., Chen C.R., Manova-Todorova K., Blasberg R., Gerald W.L., and Massague J. Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc. Natl. Acad. Sci. USA 102 (2005) 13909-13914
16. Kleihues P., Louis D.N., Scheithauer B.W., Rorke L.B., Reifenberger G., Burger P.C., and Cavenee W.K. The WHO classification of tumors of the nervous system. J. Neuropathol. Exp. Neurol. 61 (2002) 215-225
17. Lee J., Kotliarova S., Kotliarov Y., Li A., Su Q., Donin N.M., Pastorino S., Purow B.W., Christopher N., Zhang W., et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9 (2006) 391-403
18. Lou S.M., Li Y.M., Wang K.M., Cai W.M., and Weng H.L. Expression of platelet-derived growth factor-BB in liver tissues of patients with chronic hepatitis B. World J. Gastroenterol. 10 (2004) 385-388
19. Maher E.A., Furnari F.B., Bachoo R.M., Rowitch D.H., Louis D.N., Cavenee W.K., and DePinho R.A. Malignant glioma: Genetics and biology of a grave matter. Genes Dev. 15 (2001) 1311-1333
20. Massague J., Seoane J., and Wotton D. Smad transcription factors. Genes Dev. 19 (2005) 2783-2810
21. Moustakas A., and Heldin C.H. Non-Smad TGF-β signals. J. Cell Sci. 118 (2005) 3573-3584
22. Ostman A. PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. Cytokine Growth Factor Rev. 15 (2004) 275-286
23. Piek E., Westermark U., Kastemar M., Heldin C.H., van Zoelen E.J., Nister M., and Ten Dijke P. Expression of transforming-growth-factor (TGF)-beta receptors and Smad proteins in glioblastoma cell lines with distinct responses to TGF-β1. Int. J. Cancer 80 (1999) 756-763
24. Rich J.N. The role of transforming growth factor-beta in primary brain tumors. Front. Biosci. 8 (2003) e245-e260
25. Rich J.N., Zhang M., Datto M.B., Bigner D.D., and Wang X.F. Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines. J. Biol. Chem. 274 (1999) 35053-35058
26. Sanai N., Alvarez-Buylla A., and Berger M.S. Neural stem cells and the origin of gliomas. N. Engl. J. Med. 353 (2005) 811-822
27. Seoane J. Escaping from the TGFβ anti-proliferative control. Carcinogenesis 27 (2006) 2148-2156
28. Seoane J., Le H.V., Shen L., Anderson S.A., and Massague J. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117 (2004) 211-223
29. Siegel P.M., and Massague J. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat. Rev. Cancer 3 (2003) 807-821
30. Taylor L.M., and Khachigian L.M. Induction of platelet-derived growth factor B-chain expression by transforming growth factor-beta involves transactivation by Smads. J. Biol. Chem. 275 (2000) 16709-16716
31. Toda S., Nishimura T., Yamada S., Koike N., Yonemitsu N., Watanabe K., Matsumura S., Gartner R., and Sugihara H. Immunohistochemical expression of growth factors in subacute thyroiditis and their effects on thyroid folliculogenesis and angiogenesis in collagen gel matrix culture. J. Pathol. 188 (1999) 415-422
32. van Beusechem V.W., Grill J., Mastenbroek D.C., Wickham T.J., Roelvink P.W., Haisma H.J., Lamfers M.L., Dirven C.M., Pinedo H.M., and Gerritsen W.R. Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished. J. Virol. 76 (2002) 2753-2762
33. Wu H., Chen Y., Liang J., Shi B., Wu G., Zhang Y., Wang D., Li R., Yi X., Zhang H., et al. Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature 438 (2005) 981-987
34. Yingling J.M., Blanchard K.L., and Sawyer J.S. Development of TGF-β signalling inhibitors for cancer therapy. Nat. Rev. Drug Discov. 3 (2004) 1011-1022
35. Zhu Y., and Parada L.F. The molecular and genetic basis of neurological tumours. Nat. Rev. Cancer 2 (2002) 616-626